WHAT WE AIM TO DO


DELIVER RELIABLE,ACCESSIBLE,
UP-TO-DATE EVIDENCE

The Australian Living Evidence Consortium is pioneering the development and deployment of a world-first, end-to-end, closed-loop evidence system for near real-time updating of systematic reviews and clinical practice guideline recommendations within the Australian health system.

The Consortium is developing the platforms, processes and partnerships needed to synthesise large volumes of research and deliver reliable, accessible, up-to-date evidence to patients, health professionals and policymakers faster, more efficiently and more effectively.

We want to bring Australia’s evidence ecosystem into the 21st century, moving from a system that is outdated, fragmented, slow, expensive and inefficient to one that is modern, integrated, rapid, efficient and trustworthy.

BREAK THE TRADE OFF BETWEEN EVIDENCE QUALITY AND CURRENCY

Harnessing automation technologies, citizen science, data science, data linkage and the rapidly evolving landscape of health data analytics, we aim to deliver substantial increases in research value and impact. Living Evidence has the potential to reduce the time lag between publication of new research, incorporation into a systematic review, updating of evidence-based guideline recommendations and dissemination to decision makers from several years to around 8 weeks.

Health system-wide scale up of Living Evidence systems will require significant investment and represent a major new health and research infrastructure project impacting multiple portfolios across Commonwealth, State and Territory Governments.

This is why our program model is taking a phased approach to the development and roll out of Living Evidence. Frontier Projects in stroke, diabetes, kidney disease, musculoskeletal conditions, heart disease and COVID-19 will provide the thrust of early pilot, testing and evaluation work needed to demonstrate feasibility, provide evidence of health and economic benefit and guide future investment and expansion into other clinical areas.